An FMR1 genetic study was repeated by our lab with updated techniques: RT-PCR was used to rule out mosaicism, methylation studies were performed to confirm full methylation or partial methylation, and XCI analysis was requested to study preferential inactivation in one young woman with FM and absence of a clear FXS phenotype. This evidence concerns the gene FMR1 and fragile X syndrome.